To investigate the clinical significance of FABP4 and FABP6 expression, the serum FABP4 and FABP6 levels were categorized into low (< the median) or high (≥ the median) according to a cutoff value calculated from the median of the values observed in the CRC subjects. Here, FABP4 is linked to colorectal carcinoma.